This Article Full Text Full Text (PDF) All Versions of this Article: 97/4/323    most recent 01.RES.0000179035.20319.c2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zou, L. Articles by Tian, R. Search for Related Content PubMed PubMed Citation Articles by Zou, L. Articles by Tian, R. Related Collections Biochemistry and metabolism Genetically altered mice Ischemic biology - basic studies

(Circulation Research. 2005;97:323.)
© 2005 American Heart Association, Inc.

Molecular Medicine

N488I Mutation of the 2-Subunit Results in Bidirectional Changes in AMP-Activated Protein Kinase Activity

Liqun Zou^*, Mei Shen^*, Michael Arad, Huamei He, Bo Løfgren, Joanne S. Ingwall, Christine E. Seidman, Jon G. Seidman, Rong Tian

From the NMR Laboratory for Physiological Chemistry (L.Z., M.S., H.H., B.L., J.S.I., R.T.), Division of Cardiovascular Medicine (C.E.S.), Brigham and Women’s Hospital, and the Department of Genetics (M.A., C.E.S., J.G.S.), Harvard Medical School, Boston, Mass.

Correspondence to Dr Rong Tian, NMR Laboratory for Physiological Chemistry, 221 Longwood Ave, Rm 252, Boston, MA 02115. E-mail rtian{at}rics.bwh.harvard.edu

Mutations in the human gene encoding the nucleotide-binding region in the -subunit of AMP-activated protein kinase (AMPK) cause cardiomyopathy with preexcitation syndrome. Mutant AMPK showed reduced binding affinity to nucleotides in vitro raising the possibility that altered regulation of AMPK activity by AMP/ATP could contribute to the disease phenotype. In this study, we determined the sensitivity of AMPK activity to AMP/ATP in the beating hearts using transgenic mice expressing a mutant (N488I, 2-mutant) or wild-type 2-subunit (2-TG). The [ATP] and [AMP] were unaltered in all hearts but the AMPK activity was increased by 2.5-fold in 2-mutant hearts freeze-clamped at normal AMP/ATP compared with nontransgenic (WT) or 2-TG. The increased basal AMPK activity was caused by increased Thr-172 phosphorylation of the -subunit (p-AMPK, by 4-fold) at normal [ATP] and was not changed by reducing glycogen content by 60% in the 2-mutant hearts. A reversal of AMP/ATP, caused by ATP degradation, increased p-AMPK by 7-fold in WT but caused no change in 2-mutant hearts. These results demonstrate that the mutation renders AMPK insensitive to the inhibitory and stimulatory effects of the regulatory nucleotides ATP and AMP, respectively, suggesting that the pathogenesis of the human disease may not be attributable to a simple loss- or gain-of-function.

Key Words: AMP-activated protein kinase • heart • magnetic resonance spectroscopy • mouse mutant

This article has been cited by other articles:

				A. S. Barth and G. F. Tomaselli Cardiac Metabolism and Arrhythmias Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 327 - 335. [Full Text] [PDF]

				M. Momcilovic, S. H. Iram, Y. Liu, and M. Carlson Roles of the Glycogen-binding Domain and Snf4 in Glucose Inhibition of SNF1 Protein Kinase J. Biol. Chem., July 11, 2008; 283(28): 19521 - 19529. [Abstract] [Full Text] [PDF]

				L. H. Young AMP-Activated Protein Kinase Conducts the Ischemic Stress Response Orchestra Circulation, February 12, 2008; 117(6): 832 - 840. [Full Text] [PDF]

				K. D. Folmes, L. A. Witters, M. F. Allard, M. E. Young, and J. R. B. Dyck The AMPK {gamma}1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3456 - H3464. [Abstract] [Full Text] [PDF]

				M. Arad, C. E. Seidman, and J.G. Seidman AMP-Activated Protein Kinase in the Heart: Role During Health and Disease Circ. Res., March 2, 2007; 100(4): 474 - 488. [Abstract] [Full Text] [PDF]

				V. W. Dolinsky and J. R. B. Dyck Role of AMP-activated protein kinase in healthy and diseased hearts Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2557 - H2569. [Abstract] [Full Text] [PDF]

				M. Xie, D. Zhang, J. R. B. Dyck, Y. Li, H. Zhang, M. Morishima, D. L. Mann, G. E. Taffet, A. Baldini, D. S. Khoury, et al. A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway PNAS, November 14, 2006; 103(46): 17378 - 17383. [Abstract] [Full Text] [PDF]

				J. Li, D. L. Coven, E. J. Miller, X. Hu, M. E. Young, D. Carling, A. J. Sinusas, and L. H. Young Activation of AMPK {alpha}- and {gamma}-isoform complexes in the intact ischemic rat heart Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1927 - H1934. [Abstract] [Full Text] [PDF]

				J. R. B. Dyck and G. D. Lopaschuk AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol., July 1, 2006; 574(1): 95 - 112. [Abstract] [Full Text] [PDF]

				J. K. Davies, D. J. Wells, K. Liu, H. R. Whitrow, T. D. Daniel, R. Grignani, C. A. Lygate, J. E. Schneider, G. Noel, H. Watkins, et al. Characterization of the role of {gamma}2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1942 - H1951. [Abstract] [Full Text] [PDF]

				F. Ahmad, M. Arad, N. Musi, H. He, C. Wolf, D. Branco, A. R. Perez-Atayde, D. Stapleton, D. Bali, Y. Xing, et al. Increased {alpha}2 Subunit-Associated AMPK Activity and PRKAG2 Cardiomyopathy Circulation, November 15, 2005; 112(20): 3140 - 3148. [Abstract] [Full Text] [PDF]